Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,036 | 62 | 99.5% |
| Education | $5.26 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $646.06 | 18 | $0 (2021) |
| Allergan Inc. | $199.43 | 33 | $0 (2018) |
| ABBVIE INC. | $86.69 | 5 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $38.04 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $18.90 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $18.05 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $11.73 | 1 | $0 (2018) |
| Genentech USA, Inc. | $11.33 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $11.07 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $55.49 | 3 | ABBVIE INC. ($55.49) |
| 2021 | $214.27 | 4 | Janssen Pharmaceuticals, Inc ($183.07) |
| 2020 | $90.33 | 1 | Janssen Pharmaceuticals, Inc ($90.33) |
| 2019 | $246.35 | 6 | Janssen Pharmaceuticals, Inc ($246.35) |
| 2018 | $230.27 | 16 | Janssen Pharmaceuticals, Inc ($126.31) |
| 2017 | $204.59 | 33 | Allergan Inc. ($174.62) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/18/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $98.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/20/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $84.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
| 02/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE | ||||||
| 01/07/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $90.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/29/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $79.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/10/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Education | In-kind items and services | $5.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/10/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $100.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/23/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $52.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $3.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/21/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Virology & Specialty Care | ||||||
| 11/20/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $18.37 | General |
| Category: AED | ||||||
| 11/16/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/30/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $84.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/04/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/20/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $19.67 | General |
| Category: AED | ||||||
| 07/10/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/05/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.73 | General |
| Category: Cardiovascular | ||||||
| 05/14/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 672 | 824 | $126,214 | $39,955 |
| 2021 | 22 | 1,256 | 1,890 | $245,274 | $93,710 |
| 2020 | 25 | 1,490 | 2,175 | $241,827 | $87,246 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 292 | $71,248 | $17,690 | 24.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 88 | 88 | $27,368 | $10,746 | 39.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $8,406 | $5,039 | 59.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 61 | $10,492 | $3,061 | 29.2% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 42 | 42 | $3,360 | $1,539 | 45.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 54 | 65 | $1,885 | $598.52 | 31.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 156 | 196 | $1,568 | $574.01 | 36.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 17 | 17 | $850.00 | $468.54 | 55.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 19 | $855.00 | $179.87 | 21.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 24 | 26 | $182.00 | $58.10 | 31.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 251 | 537 | $122,436 | $42,065 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 170 | 170 | $49,300 | $21,294 | 43.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 92 | 120 | $19,200 | $6,934 | 36.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 68 | 68 | $5,304 | $4,429 | 83.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 25 | 25 | $9,250 | $3,666 | 39.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 27 | $8,586 | $2,949 | 34.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 16 | 16 | $5,936 | $2,556 | 43.1% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 55 | 55 | $4,400 | $2,055 | 46.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $1,650 | $1,367 | 82.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 82 | 138 | $3,864 | $1,313 | 34.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 230 | 417 | $3,336 | $1,237 | 37.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 68 | 68 | $3,332 | $1,080 | 32.4% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 26 | 26 | $2,080 | $971.36 | 46.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 12 | 14 | $1,886 | $448.02 | 23.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 11 | 12 | $1,080 | $369.12 | 34.2% |
About Dr. Jeffrey Schoon, DO
Dr. Jeffrey Schoon, DO is a Family Medicine healthcare provider based in West Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003876863.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Schoon, DO has received a total of $1,041 in payments from pharmaceutical and medical device companies, with $55.49 received in 2022. These payments were reported across 63 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,036).
As a Medicare-enrolled provider, Schoon has provided services to 3,418 Medicare beneficiaries, totaling 4,889 services with total Medicare billing of $220,911. Data is available for 3 years (2020–2022), covering 57 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location West Des Moines, IA
- Active Since 03/24/2006
- Last Updated 08/09/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1003876863
Products in Payments
- XARELTO (Drug) $403.71
- INVOKANA (Drug) $242.35
- UBRELVY (Drug) $86.69
- VIBERZI (Drug) $70.49
- LINZESS (Drug) $59.41
- TROKENDI XR (Drug) $38.04
- BYSTOLIC (Drug) $34.32
- VRAYLAR (Drug) $19.49
- ENTRESTO (Drug) $18.90
- PRALUENT (Drug) $18.05
- ELIQUIS (Drug) $11.73
- Xofluza (Drug) $11.33
- PRADAXA (Drug) $11.07
- NAMZARIC (Drug) $9.46
- VIIBRYD (Drug) $4.02
- BYVALSON (Drug) $2.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in West Des Moines
Basil Hassan, Md, MD
Family Medicine — Payments: $17,360
Dawn Schissel, Md, MD
Family Medicine — Payments: $17,086
Dale Grunewald, D.o, D.O
Family Medicine — Payments: $12,944
Mr. Jeffrey Lenz, Md, MD
Family Medicine — Payments: $9,710
Malea Jensen, Do, DO
Family Medicine — Payments: $9,418
Majed Barazanji, M.d, M.D
Family Medicine — Payments: $8,911